Age, Biography and Wiki
Earl Davie was born on 25 October, 1927 in Tacoma, Washington, is an American biochemist (1927–2020). Discover Earl Davie's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is he in this year and how he spends money? Also learn how he earned most of networth at the age of 92 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
92 years old |
| Zodiac Sign |
Scorpio |
| Born |
25 October, 1927 |
| Birthday |
25 October |
| Birthplace |
Tacoma, Washington |
| Date of death |
6 June, 2020 |
| Died Place |
Bellevue, Washington |
| Nationality |
United States
|
We recommend you to check the complete list of Famous People born on 25 October.
He is a member of famous with the age 92 years old group.
Earl Davie Height, Weight & Measurements
At 92 years old, Earl Davie height not available right now. We will update Earl Davie's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.
| Family |
| Parents |
Not Available |
| Wife |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Earl Davie Net Worth
His net worth has been growing significantly in 2023-2024. So, how much is Earl Davie worth at the age of 92 years old? Earl Davie’s income source is mostly from being a successful . He is from United States. We have estimated Earl Davie's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Earl Davie Social Network
| Instagram |
|
| Linkedin |
|
| Twitter |
|
| Facebook |
|
| Wikipedia |
|
| Imdb |
|
Timeline
Earl Warren Davie (October 25, 1927 - June 6, 2020) was an American biochemist.
He was a professor emeritus of biochemistry at the University of Washington.
Davie studied the blood proteins involved in coagulation and was among the first scientists to describe the steps of the clotting process.
He was a member of the National Academy of Sciences and a fellow of the American Academy of Arts and Sciences.
Davie was born on October 25, 1927, in Tacoma, Washington, to Charles and Teckla Davie.
He grew up in La Grande, Washington and attended Eatonville High School.
He received an undergraduate degree in 1950 from the University of Washington, where he had worked in the laboratory of biochemistry professor Donald Hanahan.
He completed a Ph.D. at UW in 1954.
During his doctoral studies, Davie worked with Hans Neurath to learn about protein structure and function.
After a postdoctoral fellowship with Fritz Lipmann at Harvard Medical School, Davie worked at the Case Western Reserve University School of Medicine from 1957 to 1962, where he met hematologist Oscar Ratnoff, the discoverer of Hageman factor (later known as factor XII).
He then returned to the University of Washington, later chairing the biochemistry department for several years.
Davie has made significant research contributions to the understanding of coagulation.
Davie and Ratnoff described the sequence of steps in the clotting cascade.
Davie and Ratnoff published their clotting cascade model in 1964, around the same time that Robert Gwyn Macfarlane of the University of Oxford produced a similar model.
In 1980, Davie was elected to the National Academy of Sciences.
Davie cofounded a biotechnology company, ZymoGenetics, in 1981.
He was named a fellow of the American Academy of Arts and Sciences in 1987.
In 1993, Davie awarded the Stratton Medal from the American Society of Hematology; he was named a Legend in Hematology by the society in 2008.
He received a Distinguished Achievement Award from the American Heart Association in 1995.
The Centre for Blood Research at the University of British Columbia established the Earl W. Davie Symposium in his honor.
The company was purchased by Novo Nordisk several years later; in 2000, ZymoGenetics was recreated as an independent company and it was acquired by Bristol-Myers Squibb in 2010.
